AstraZeneca's revenue 2013-2023 by region
In 2023, AstraZeneca's U.S. revenue stood at over 19 billion U.S. dollars. But AstraZeneca is one of the rare big pharma companies for which emerging countries constitute one of its top single markets. This statistic shows the revenue of pharmaceutical company AstraZeneca worldwide from 2013 to 2023, by region. AstraZeneca plc is a leading pharmaceutical company worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.